| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Notch1 | 75 | 2017 | 495 | 6.300 |
Why?
|
| Receptors, Notch | 54 | 2017 | 743 | 5.050 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 29 | 2017 | 381 | 3.570 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 17 | 2010 | 164 | 2.410 |
Why?
|
| Signal Transduction | 90 | 2017 | 23376 | 1.570 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 19 | 2017 | 121 | 1.440 |
Why?
|
| Gene Expression Regulation, Leukemic | 11 | 2017 | 646 | 1.280 |
Why?
|
| Receptors, Cell Surface | 28 | 2004 | 2825 | 1.270 |
Why?
|
| Membrane Proteins | 48 | 2015 | 7850 | 1.050 |
Why?
|
| Transcriptional Activation | 16 | 2011 | 1755 | 1.030 |
Why?
|
| Transcription Factors | 49 | 2017 | 12103 | 0.920 |
Why?
|
| Proto-Oncogene Proteins c-myc | 12 | 2017 | 995 | 0.880 |
Why?
|
| Leukemia, T-Cell | 6 | 2011 | 101 | 0.850 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2017 | 1356 | 0.840 |
Why?
|
| Carcinoma, Adenoid Cystic | 3 | 2017 | 262 | 0.700 |
Why?
|
| Gene Expression Regulation, Neoplastic | 31 | 2017 | 8515 | 0.690 |
Why?
|
| Cell Transformation, Neoplastic | 16 | 2014 | 2828 | 0.620 |
Why?
|
| Ankyrin Repeat | 3 | 2011 | 19 | 0.620 |
Why?
|
| Mutation | 47 | 2019 | 29932 | 0.620 |
Why?
|
| Oncogene Proteins, Fusion | 16 | 2016 | 1596 | 0.600 |
Why?
|
| Drug Resistance, Neoplasm | 11 | 2018 | 5253 | 0.590 |
Why?
|
| Response Elements | 4 | 2017 | 308 | 0.570 |
Why?
|
| Translocation, Genetic | 15 | 2016 | 1388 | 0.570 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 12 | 2016 | 1403 | 0.570 |
Why?
|
| Neoplasm Proteins | 12 | 2016 | 3610 | 0.560 |
Why?
|
| Nuclear Proteins | 24 | 2016 | 5791 | 0.560 |
Why?
|
| Protein Structure, Tertiary | 24 | 2014 | 3800 | 0.520 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 | 2014 | 1547 | 0.520 |
Why?
|
| Promoter Regions, Genetic | 16 | 2017 | 5785 | 0.470 |
Why?
|
| Amyloid Precursor Protein Secretases | 12 | 2017 | 620 | 0.470 |
Why?
|
| Phenothiazines | 2 | 2014 | 61 | 0.460 |
Why?
|
| DNA-Binding Proteins | 32 | 2012 | 9585 | 0.450 |
Why?
|
| Animals | 130 | 2019 | 167963 | 0.450 |
Why?
|
| Cell Line, Tumor | 36 | 2017 | 16939 | 0.440 |
Why?
|
| Genome, Human | 3 | 2017 | 4417 | 0.440 |
Why?
|
| Bone Marrow Transplantation | 14 | 2011 | 2693 | 0.440 |
Why?
|
| Ribonuclease III | 1 | 2015 | 279 | 0.440 |
Why?
|
| Hematopoietic Stem Cells | 19 | 2017 | 3387 | 0.430 |
Why?
|
| T-Lymphocytes | 24 | 2014 | 10181 | 0.430 |
Why?
|
| Oncogenes | 9 | 2017 | 1220 | 0.430 |
Why?
|
| Receptor, Notch2 | 8 | 2014 | 87 | 0.430 |
Why?
|
| Mice | 91 | 2019 | 81208 | 0.420 |
Why?
|
| Oncogene Proteins | 5 | 2011 | 719 | 0.420 |
Why?
|
| B-Lymphocytes | 18 | 2017 | 4742 | 0.410 |
Why?
|
| Transcription, Genetic | 14 | 2016 | 7593 | 0.410 |
Why?
|
| Leukemia | 10 | 2017 | 1520 | 0.410 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 236 | 0.390 |
Why?
|
| 5'-Nucleotidase | 1 | 2013 | 161 | 0.390 |
Why?
|
| Neoplasms | 16 | 2018 | 22072 | 0.380 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 11 | 2015 | 1652 | 0.380 |
Why?
|
| Immune System Diseases | 1 | 2014 | 258 | 0.380 |
Why?
|
| Gene Expression Regulation | 9 | 2015 | 11903 | 0.370 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2010 | 431 | 0.360 |
Why?
|
| Cell Proliferation | 19 | 2017 | 10446 | 0.350 |
Why?
|
| Lymphoma, B-Cell | 10 | 2017 | 935 | 0.350 |
Why?
|
| Antineoplastic Agents | 10 | 2017 | 13630 | 0.350 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2010 | 100 | 0.350 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.350 |
Why?
|
| Lymphoma, T-Cell | 6 | 2008 | 305 | 0.340 |
Why?
|
| Cell Differentiation | 26 | 2017 | 11481 | 0.330 |
Why?
|
| Antibodies | 4 | 2015 | 2421 | 0.320 |
Why?
|
| Apoptosis | 12 | 2015 | 9501 | 0.320 |
Why?
|
| Conserved Sequence | 4 | 2010 | 1167 | 0.310 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1894 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2006 | 246 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2006 | 286 | 0.300 |
Why?
|
| Herpesviridae Infections | 4 | 2006 | 270 | 0.300 |
Why?
|
| Humans | 201 | 2019 | 760621 | 0.300 |
Why?
|
| Cyclins | 3 | 2008 | 593 | 0.300 |
Why?
|
| Multiprotein Complexes | 2 | 2013 | 1120 | 0.300 |
Why?
|
| Hematologic Neoplasms | 4 | 2016 | 1895 | 0.300 |
Why?
|
| Molecular Sequence Data | 26 | 2014 | 17624 | 0.290 |
Why?
|
| Cell Lineage | 15 | 2017 | 2533 | 0.290 |
Why?
|
| Luciferases | 7 | 2014 | 716 | 0.290 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2011 | 788 | 0.280 |
Why?
|
| Lymphoma | 7 | 2016 | 1898 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 1347 | 0.280 |
Why?
|
| Gene Expression Profiling | 19 | 2018 | 9411 | 0.270 |
Why?
|
| Endopeptidases | 7 | 2007 | 772 | 0.270 |
Why?
|
| Myeloproliferative Disorders | 7 | 2017 | 609 | 0.270 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2008 | 169 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2015 | 2873 | 0.260 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2015 | 2418 | 0.260 |
Why?
|
| Down-Regulation | 6 | 2014 | 2913 | 0.250 |
Why?
|
| In Situ Hybridization, Fluorescence | 10 | 2017 | 2506 | 0.240 |
Why?
|
| Dimerization | 9 | 2010 | 891 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 10 | 2019 | 6131 | 0.240 |
Why?
|
| Amino Acid Sequence | 19 | 2017 | 13451 | 0.240 |
Why?
|
| Plasmids | 7 | 2014 | 2275 | 0.240 |
Why?
|
| Homeodomain Proteins | 6 | 2012 | 2414 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 2 | 2017 | 32 | 0.230 |
Why?
|
| Lymphocytes | 6 | 2006 | 2611 | 0.230 |
Why?
|
| Herpesvirus 4, Human | 7 | 2011 | 1075 | 0.230 |
Why?
|
| Genes, myc | 4 | 2014 | 395 | 0.230 |
Why?
|
| Blotting, Western | 14 | 2016 | 5039 | 0.220 |
Why?
|
| Mediastinal Neoplasms | 4 | 2011 | 402 | 0.220 |
Why?
|
| Oncogene Protein v-akt | 2 | 2015 | 129 | 0.220 |
Why?
|
| Sequence Deletion | 8 | 2013 | 1493 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2015 | 4573 | 0.220 |
Why?
|
| Lens, Crystalline | 5 | 1986 | 388 | 0.220 |
Why?
|
| Bone Marrow | 5 | 2010 | 2912 | 0.220 |
Why?
|
| Protease Inhibitors | 4 | 2014 | 755 | 0.220 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2010 | 1375 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2882 | 0.220 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 4 | 2011 | 157 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2016 | 1407 | 0.210 |
Why?
|
| Genes, bcl-2 | 2 | 2007 | 119 | 0.210 |
Why?
|
| Cell Line | 23 | 2015 | 15620 | 0.210 |
Why?
|
| Transfection | 15 | 2015 | 5781 | 0.210 |
Why?
|
| Hematopoiesis | 8 | 2017 | 2050 | 0.210 |
Why?
|
| Trans-Activators | 14 | 2013 | 2860 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2015 | 3790 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 8 | 2018 | 5643 | 0.200 |
Why?
|
| Base Sequence | 13 | 2016 | 12446 | 0.200 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11071 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2017 | 3584 | 0.200 |
Why?
|
| Calcium-Binding Proteins | 12 | 2015 | 1067 | 0.190 |
Why?
|
| Disease Models, Animal | 17 | 2019 | 18137 | 0.190 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 801 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2010 | 3663 | 0.190 |
Why?
|
| Genes, Immunoglobulin | 1 | 2002 | 285 | 0.190 |
Why?
|
| Protein Binding | 14 | 2017 | 9335 | 0.190 |
Why?
|
| Thymus Gland | 9 | 2011 | 1247 | 0.190 |
Why?
|
| Gene Rearrangement | 6 | 2017 | 1122 | 0.190 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2002 | 167 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2011 | 2753 | 0.180 |
Why?
|
| Repressor Proteins | 8 | 2013 | 2981 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 13 | 2009 | 3735 | 0.180 |
Why?
|
| Hodgkin Disease | 4 | 2005 | 1378 | 0.180 |
Why?
|
| Antibody Specificity | 5 | 2013 | 1060 | 0.180 |
Why?
|
| Peptides | 6 | 2011 | 4354 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 4 | 2009 | 533 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 8 | 2016 | 9185 | 0.170 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2016 | 223 | 0.170 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 2 | 2010 | 85 | 0.170 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 2105 | 0.170 |
Why?
|
| Cells, Cultured | 19 | 2015 | 18957 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 9 | 5 | 2008 | 534 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-rel | 5 | 2006 | 71 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 5 | 2000 | 1343 | 0.170 |
Why?
|
| Carcinoma | 2 | 2009 | 2331 | 0.170 |
Why?
|
| Binding Sites | 10 | 2013 | 6048 | 0.170 |
Why?
|
| Blood Proteins | 4 | 1986 | 1173 | 0.170 |
Why?
|
| Lymphoma, Follicular | 2 | 2002 | 453 | 0.170 |
Why?
|
| Genetic Variation | 3 | 2016 | 6551 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 4 | 2011 | 608 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2019 | 3602 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2014 | 4024 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2007 | 362 | 0.160 |
Why?
|
| Chromosome Aberrations | 7 | 2016 | 1764 | 0.160 |
Why?
|
| Neuropeptides | 4 | 1986 | 943 | 0.160 |
Why?
|
| Isoquinolines | 2 | 2017 | 353 | 0.160 |
Why?
|
| Ikaros Transcription Factor | 2 | 2010 | 231 | 0.160 |
Why?
|
| Ligands | 13 | 2015 | 3276 | 0.160 |
Why?
|
| Blotting, Southern | 6 | 2010 | 777 | 0.160 |
Why?
|
| Models, Biological | 14 | 2017 | 9467 | 0.160 |
Why?
|
| Sulfonamides | 4 | 2016 | 1977 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2012 | 4490 | 0.150 |
Why?
|
| Burkitt Lymphoma | 1 | 2000 | 333 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 1999 | 172 | 0.150 |
Why?
|
| Calcium | 7 | 2003 | 5725 | 0.150 |
Why?
|
| Cell Cycle Proteins | 8 | 2014 | 3446 | 0.150 |
Why?
|
| Aspartic Acid Endopeptidases | 6 | 2005 | 311 | 0.150 |
Why?
|
| Cell Cycle | 8 | 2016 | 2934 | 0.150 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2010 | 235 | 0.150 |
Why?
|
| Phosphorylation | 10 | 2014 | 8313 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2018 | 717 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2014 | 656 | 0.150 |
Why?
|
| Blotting, Northern | 3 | 2010 | 1543 | 0.150 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 251 | 0.140 |
Why?
|
| Chromatin | 5 | 2016 | 2938 | 0.140 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 2 | 2017 | 209 | 0.140 |
Why?
|
| Mice, Transgenic | 15 | 2019 | 9530 | 0.140 |
Why?
|
| Transduction, Genetic | 4 | 2011 | 897 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2014 | 858 | 0.140 |
Why?
|
| Models, Molecular | 12 | 2016 | 5434 | 0.140 |
Why?
|
| Point Mutation | 6 | 2009 | 1594 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2015 | 3604 | 0.140 |
Why?
|
| Herpesvirus 8, Human | 1 | 1998 | 255 | 0.140 |
Why?
|
| Animals, Genetically Modified | 5 | 2015 | 1553 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
| 3T3 Cells | 8 | 2012 | 1085 | 0.130 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 124 | 0.130 |
Why?
|
| Tretinoin | 1 | 2019 | 519 | 0.130 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2016 | 82 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 8 | 2011 | 1139 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2014 | 1055 | 0.130 |
Why?
|
| Genes, Reporter | 7 | 2014 | 1529 | 0.130 |
Why?
|
| DNA Primers | 3 | 2013 | 2819 | 0.130 |
Why?
|
| Megakaryocytes | 2 | 2011 | 565 | 0.130 |
Why?
|
| Retroviridae | 7 | 2003 | 850 | 0.130 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2016 | 495 | 0.130 |
Why?
|
| Protein Kinase C | 2 | 2012 | 1199 | 0.130 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2015 | 86 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Sarcoma, Kaposi | 1 | 1998 | 376 | 0.120 |
Why?
|
| Macaca mulatta | 4 | 2006 | 2316 | 0.120 |
Why?
|
| Mutation, Missense | 4 | 2016 | 2566 | 0.120 |
Why?
|
| Cyclin C | 1 | 2014 | 12 | 0.120 |
Why?
|
| Crystallins | 2 | 1985 | 75 | 0.120 |
Why?
|
| Clone Cells | 7 | 2017 | 1660 | 0.120 |
Why?
|
| Milk Proteins | 3 | 2000 | 163 | 0.120 |
Why?
|
| Spectrin | 2 | 1986 | 170 | 0.120 |
Why?
|
| Saphenous Vein | 2 | 2015 | 537 | 0.120 |
Why?
|
| Neointima | 1 | 2015 | 134 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2015 | 85 | 0.120 |
Why?
|
| Drosophila | 5 | 2013 | 1492 | 0.120 |
Why?
|
| Protein Conformation | 5 | 2016 | 3969 | 0.120 |
Why?
|
| Flow Cytometry | 11 | 2016 | 5870 | 0.120 |
Why?
|
| Lymphocryptovirus | 2 | 2004 | 14 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 331 | 0.120 |
Why?
|
| HEK293 Cells | 8 | 2015 | 4264 | 0.120 |
Why?
|
| Zebrafish | 7 | 2015 | 2997 | 0.120 |
Why?
|
| Skin Neoplasms | 4 | 2017 | 5799 | 0.120 |
Why?
|
| Renilla | 1 | 2014 | 6 | 0.120 |
Why?
|
| Genes, Essential | 1 | 2015 | 184 | 0.120 |
Why?
|
| Perphenazine | 1 | 2014 | 33 | 0.120 |
Why?
|
| Purines | 1 | 2017 | 605 | 0.120 |
Why?
|
| Cell Survival | 6 | 2017 | 5797 | 0.120 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2013 | 40 | 0.120 |
Why?
|
| Valine | 1 | 2015 | 409 | 0.110 |
Why?
|
| Neoplasm Transplantation | 8 | 2016 | 2014 | 0.110 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 304 | 0.110 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1996 | 94 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2017 | 3616 | 0.110 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 8 | 2011 | 2057 | 0.110 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 895 | 0.110 |
Why?
|
| Pigmentation | 1 | 2014 | 144 | 0.110 |
Why?
|
| Copper Radioisotopes | 1 | 2013 | 89 | 0.110 |
Why?
|
| Erythrocyte Membrane | 6 | 1984 | 439 | 0.110 |
Why?
|
| Alleles | 7 | 2016 | 6898 | 0.110 |
Why?
|
| Recombinant Proteins | 8 | 2011 | 6538 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 410 | 0.110 |
Why?
|
| Enzyme Assays | 1 | 2014 | 107 | 0.110 |
Why?
|
| Dopamine Antagonists | 1 | 2014 | 288 | 0.110 |
Why?
|
| Genetic Techniques | 3 | 2002 | 428 | 0.110 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 929 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 16 | 2019 | 22023 | 0.100 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2012 | 57 | 0.100 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 534 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 5130 | 0.100 |
Why?
|
| Multigene Family | 2 | 2007 | 1077 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1091 | 0.100 |
Why?
|
| Betapapillomavirus | 1 | 2012 | 6 | 0.100 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1992 | 37 | 0.100 |
Why?
|
| Biophysical Phenomena | 2 | 2011 | 320 | 0.100 |
Why?
|
| Indazoles | 1 | 2014 | 302 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 128 | 0.100 |
Why?
|
| Carrier Proteins | 8 | 2003 | 4938 | 0.100 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4107 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 866 | 0.100 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2010 | 685 | 0.100 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 458 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 633 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 8 | 2 | 2014 | 48 | 0.100 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 351 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2007 | 704 | 0.100 |
Why?
|
| Immunity | 2 | 2016 | 998 | 0.100 |
Why?
|
| Cell Nucleus | 5 | 2007 | 2907 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2009 | 191 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2012 | 1115 | 0.100 |
Why?
|
| Glycolysis | 1 | 2015 | 828 | 0.100 |
Why?
|
| Cell Line, Transformed | 5 | 2006 | 869 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6544 | 0.100 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2011 | 67 | 0.100 |
Why?
|
| Mice, Knockout | 9 | 2015 | 14372 | 0.090 |
Why?
|
| RNA, Messenger | 9 | 2014 | 12766 | 0.090 |
Why?
|
| Structure-Activity Relationship | 4 | 2011 | 3084 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 135 | 0.090 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1992 | 419 | 0.090 |
Why?
|
| Metalloproteins | 1 | 2011 | 101 | 0.090 |
Why?
|
| Organ Culture Techniques | 2 | 2011 | 796 | 0.090 |
Why?
|
| Gene Duplication | 2 | 2016 | 313 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 1992 | 445 | 0.090 |
Why?
|
| Male | 42 | 2017 | 359744 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2019 | 11712 | 0.090 |
Why?
|
| Enzyme Inhibitors | 5 | 2014 | 3726 | 0.090 |
Why?
|
| Zebrafish Proteins | 2 | 2015 | 1006 | 0.090 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2012 | 341 | 0.090 |
Why?
|
| Immunophenotyping | 5 | 2016 | 1871 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2005 | 1613 | 0.090 |
Why?
|
| Leukemia, Myeloid | 3 | 2006 | 695 | 0.090 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2011 | 174 | 0.090 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2013 | 93 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 4 | 2016 | 2803 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 10827 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2016 | 2802 | 0.090 |
Why?
|
| Benzylidene Compounds | 1 | 2009 | 25 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2016 | 2627 | 0.090 |
Why?
|
| Proteins | 6 | 2004 | 6029 | 0.090 |
Why?
|
| Macrophages | 5 | 2015 | 5745 | 0.090 |
Why?
|
| Bone Neoplasms | 2 | 2013 | 2532 | 0.090 |
Why?
|
| Vestibular Diseases | 2 | 2003 | 229 | 0.080 |
Why?
|
| Cancer Vaccines | 1 | 2017 | 1046 | 0.080 |
Why?
|
| Protein Multimerization | 2 | 2015 | 983 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2864 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2008 | 385 | 0.080 |
Why?
|
| Protein Kinases | 4 | 2016 | 1612 | 0.080 |
Why?
|
| Melanoma | 3 | 2017 | 5697 | 0.080 |
Why?
|
| F-Box Proteins | 1 | 2011 | 202 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1998 | 0.080 |
Why?
|
| Transplantation, Autologous | 4 | 2010 | 2116 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 2192 | 0.080 |
Why?
|
| Cell Communication | 3 | 2015 | 1653 | 0.080 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2010 | 120 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 4902 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 380 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 8 | 2014 | 6216 | 0.080 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 258 | 0.080 |
Why?
|
| Antigens, Viral | 3 | 2010 | 980 | 0.080 |
Why?
|
| Janus Kinase 3 | 1 | 2009 | 77 | 0.080 |
Why?
|
| Janus Kinase 2 | 2 | 2009 | 542 | 0.080 |
Why?
|
| Leukemia, Experimental | 2 | 2016 | 225 | 0.080 |
Why?
|
| Bone Marrow Cells | 9 | 2012 | 2414 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2010 | 203 | 0.080 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2008 | 26 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 1998 | 452 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2000 | 192 | 0.080 |
Why?
|
| Cyclin D3 | 2 | 2008 | 54 | 0.080 |
Why?
|
| Crystallography, X-Ray | 5 | 2015 | 1982 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 286 | 0.080 |
Why?
|
| Histones | 6 | 2016 | 2583 | 0.080 |
Why?
|
| Presenilin-1 | 5 | 2004 | 660 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1728 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2015 | 2895 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 9276 | 0.080 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 1664 | 0.080 |
Why?
|
| TNF Receptor-Associated Factor 1 | 2 | 2005 | 50 | 0.080 |
Why?
|
| Lymphopoiesis | 1 | 2009 | 133 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 2 | 2006 | 428 | 0.080 |
Why?
|
| Pyrimidines | 2 | 2015 | 3016 | 0.080 |
Why?
|
| Interferon Regulatory Factors | 1 | 2009 | 260 | 0.080 |
Why?
|
| Remission Induction | 3 | 2010 | 2392 | 0.070 |
Why?
|
| Female | 46 | 2017 | 391270 | 0.070 |
Why?
|
| Histiocytosis, Sinus | 1 | 2008 | 46 | 0.070 |
Why?
|
| BCG Vaccine | 1 | 1990 | 371 | 0.070 |
Why?
|
| Serpins | 1 | 2009 | 247 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15757 | 0.070 |
Why?
|
| Base Pairing | 1 | 2008 | 140 | 0.070 |
Why?
|
| Drosophila Proteins | 5 | 2011 | 1699 | 0.070 |
Why?
|
| Proteomics | 4 | 2017 | 3817 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2010 | 1394 | 0.070 |
Why?
|
| Indoles | 3 | 2014 | 1829 | 0.070 |
Why?
|
| Drug Synergism | 3 | 2017 | 1754 | 0.070 |
Why?
|
| Oncogenic Viruses | 2 | 2004 | 37 | 0.070 |
Why?
|
| Luminescent Proteins | 4 | 2003 | 835 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 3442 | 0.070 |
Why?
|
| Viral Proteins | 3 | 2011 | 1802 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2017 | 58995 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1741 | 0.070 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2011 | 479 | 0.070 |
Why?
|
| Proviruses | 2 | 2006 | 313 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2011 | 1889 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2011 | 2919 | 0.070 |
Why?
|
| Disease Susceptibility | 3 | 2016 | 1791 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2016 | 1837 | 0.070 |
Why?
|
| Neprilysin | 1 | 2009 | 472 | 0.070 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 46 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 465 | 0.070 |
Why?
|
| Cisplatin | 1 | 2012 | 1644 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2007 | 177 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.070 |
Why?
|
| Dendritic Cells | 2 | 2016 | 2725 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1008 | 0.070 |
Why?
|
| Rhadinovirus | 1 | 2006 | 37 | 0.070 |
Why?
|
| Frameshift Mutation | 2 | 2006 | 388 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2003 | 781 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1998 | 193 | 0.070 |
Why?
|
| Genes, Dominant | 3 | 2008 | 863 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2007 | 3105 | 0.070 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 221 | 0.070 |
Why?
|
| Phenotype | 5 | 2017 | 16546 | 0.060 |
Why?
|
| Cell Division | 5 | 2009 | 4463 | 0.060 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2015 | 1067 | 0.060 |
Why?
|
| U937 Cells | 2 | 2019 | 262 | 0.060 |
Why?
|
| Computational Biology | 1 | 2018 | 3505 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2008 | 346 | 0.060 |
Why?
|
| Time Factors | 9 | 2015 | 40165 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 1612 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2006 | 1055 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 814 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2005 | 79 | 0.060 |
Why?
|
| NF-kappa B | 4 | 2008 | 2488 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1628 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 221 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 212 | 0.060 |
Why?
|
| Eosinophilia | 2 | 2003 | 559 | 0.060 |
Why?
|
| Palatine Tonsil | 1 | 2005 | 193 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 2006 | 11345 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2012 | 4878 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2008 | 556 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 12965 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2006 | 599 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 670 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2138 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 1998 | 3224 | 0.060 |
Why?
|
| Middle Aged | 21 | 2017 | 220352 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2010 | 897 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2015 | 1999 | 0.060 |
Why?
|
| Mitosis | 2 | 2007 | 1191 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2004 | 347 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2006 | 2668 | 0.060 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1991 | 0.060 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2004 | 81 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2004 | 943 | 0.060 |
Why?
|
| RNA Interference | 4 | 2015 | 2846 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 2634 | 0.060 |
Why?
|
| Tissue Distribution | 4 | 2017 | 2262 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1990 | 800 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15289 | 0.060 |
Why?
|
| Cell Movement | 3 | 2015 | 5206 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 4353 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2003 | 1974 | 0.060 |
Why?
|
| Child | 9 | 2017 | 79806 | 0.060 |
Why?
|
| Survival Rate | 7 | 2015 | 12808 | 0.050 |
Why?
|
| DNA, Neoplasm | 4 | 2001 | 1745 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2009 | 1810 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 2006 | 438 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1992 | 2536 | 0.050 |
Why?
|
| Amino Acid Substitution | 4 | 2016 | 1737 | 0.050 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2004 | 538 | 0.050 |
Why?
|
| Nevus | 1 | 2005 | 205 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2013 | 4000 | 0.050 |
Why?
|
| Metaplasia | 1 | 2004 | 320 | 0.050 |
Why?
|
| Piperazines | 3 | 2016 | 2525 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2007 | 1218 | 0.050 |
Why?
|
| Thymus Neoplasms | 1 | 2005 | 274 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 184 | 0.050 |
Why?
|
| Aged | 18 | 2017 | 169152 | 0.050 |
Why?
|
| G1 Phase | 3 | 2009 | 403 | 0.050 |
Why?
|
| Jurkat Cells | 3 | 2012 | 736 | 0.050 |
Why?
|
| Fluorouracil | 3 | 2014 | 1631 | 0.050 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2007 | 487 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2015 | 453 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 1933 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2002 | 430 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2015 | 3607 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2003 | 263 | 0.050 |
Why?
|
| Immunocompromised Host | 2 | 2004 | 857 | 0.050 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2002 | 112 | 0.050 |
Why?
|
| Exons | 1 | 2008 | 2388 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 332 | 0.050 |
Why?
|
| Adult | 21 | 2017 | 219994 | 0.050 |
Why?
|
| Binding, Competitive | 3 | 2010 | 1142 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2016 | 3484 | 0.050 |
Why?
|
| Receptors, LDL | 2 | 2015 | 488 | 0.050 |
Why?
|
| Radiation Chimera | 3 | 2009 | 216 | 0.050 |
Why?
|
| Acetylation | 2 | 2016 | 1062 | 0.050 |
Why?
|
| Bone Marrow Purging | 2 | 1998 | 108 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2010 | 3143 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 17790 | 0.050 |
Why?
|
| Disulfides | 2 | 2003 | 466 | 0.050 |
Why?
|
| Integrins | 1 | 2005 | 839 | 0.050 |
Why?
|
| Prognosis | 7 | 2017 | 29658 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2014 | 2176 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 1266 | 0.040 |
Why?
|
| Adolescent | 9 | 2017 | 87810 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3758 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2014 | 2053 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2017 | 4550 | 0.040 |
Why?
|
| Peptide Fragments | 4 | 2000 | 5125 | 0.040 |
Why?
|
| Nurses | 1 | 2010 | 2467 | 0.040 |
Why?
|
| Receptor, trkC | 1 | 2000 | 63 | 0.040 |
Why?
|
| Furin | 2 | 2011 | 46 | 0.040 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2000 | 38 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2017 | 653 | 0.040 |
Why?
|
| Calmodulin | 4 | 1982 | 217 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2011 | 311 | 0.040 |
Why?
|
| Genomics | 4 | 2018 | 5794 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 178 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2003 | 536 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2010 | 801 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 254 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2006 | 1513 | 0.040 |
Why?
|
| Cattle | 4 | 1986 | 3847 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 1763 | 0.040 |
Why?
|
| Genes, ras | 2 | 2014 | 655 | 0.040 |
Why?
|
| Ion Transport | 1 | 2000 | 318 | 0.040 |
Why?
|
| Cross Reactions | 3 | 1986 | 818 | 0.040 |
Why?
|
| Tyrosine | 2 | 2000 | 1438 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2005 | 1354 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 457 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2016 | 10182 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1617 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 1765 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2012 | 3517 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 2000 | 308 | 0.040 |
Why?
|
| Doxorubicin | 4 | 2015 | 2209 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 576 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2003 | 838 | 0.040 |
Why?
|
| Species Specificity | 3 | 2000 | 2418 | 0.040 |
Why?
|
| Transformation, Genetic | 2 | 1998 | 192 | 0.040 |
Why?
|
| Genes, Insect | 2 | 2000 | 264 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1990 | 2276 | 0.040 |
Why?
|
| Tuberculosis | 1 | 1990 | 2001 | 0.040 |
Why?
|
| Codon, Nonsense | 2 | 2011 | 281 | 0.040 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 43 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1984 | 1744 | 0.040 |
Why?
|
| HIV Seronegativity | 1 | 1998 | 208 | 0.040 |
Why?
|
| Ear, Inner | 1 | 2001 | 424 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2014 | 640 | 0.040 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1998 | 103 | 0.040 |
Why?
|
| Cell Transformation, Viral | 3 | 2006 | 526 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2016 | 3615 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2001 | 792 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.040 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 162 | 0.040 |
Why?
|
| ras Proteins | 1 | 2002 | 1052 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2007 | 3775 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1996 | 310 | 0.030 |
Why?
|
| Lung | 2 | 2006 | 9994 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1705 | 0.030 |
Why?
|
| Receptors, CXCR4 | 2 | 2015 | 728 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 384 | 0.030 |
Why?
|
| Subrenal Capsule Assay | 1 | 2016 | 27 | 0.030 |
Why?
|
| Virus Integration | 4 | 2000 | 302 | 0.030 |
Why?
|
| HL-60 Cells | 2 | 2012 | 363 | 0.030 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 2379 | 0.030 |
Why?
|
| Epitopes | 2 | 2016 | 2503 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 286 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 12626 | 0.030 |
Why?
|
| Blood Platelet Disorders | 1 | 1996 | 61 | 0.030 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 174 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1998 | 568 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2004 | 1956 | 0.030 |
Why?
|
| Artificial Cells | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2016 | 180 | 0.030 |
Why?
|
| Lod Score | 2 | 2011 | 602 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 1229 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1997 | 6068 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 3 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2017 | 877 | 0.030 |
Why?
|
| Genome, Viral | 2 | 2011 | 658 | 0.030 |
Why?
|
| Ankyrins | 2 | 2007 | 123 | 0.030 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 25 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 3 | 2000 | 264 | 0.030 |
Why?
|
| Diphenylamine | 1 | 2014 | 49 | 0.030 |
Why?
|
| Glycosylation | 2 | 2011 | 1096 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13262 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2015 | 245 | 0.030 |
Why?
|
| Fetal Stem Cells | 1 | 2014 | 10 | 0.030 |
Why?
|
| CHO Cells | 3 | 2003 | 1389 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2008 | 42063 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4625 | 0.030 |
Why?
|
| Thiadiazoles | 1 | 2014 | 64 | 0.030 |
Why?
|
| Codon | 1 | 2016 | 602 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2000 | 1110 | 0.030 |
Why?
|
| Benzamides | 2 | 2014 | 1369 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 193 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 349 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 1082 | 0.030 |
Why?
|
| Biopsy | 2 | 2017 | 6771 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 323 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 511 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 426 | 0.030 |
Why?
|
| DNA | 5 | 2007 | 7233 | 0.030 |
Why?
|
| Combined Modality Therapy | 4 | 1999 | 8552 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 58741 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1996 | 243 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 713 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2015 | 240 | 0.030 |
Why?
|
| Protons | 1 | 1999 | 1114 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
| Cricetinae | 3 | 2003 | 2427 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2005 | 3602 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2014 | 22053 | 0.030 |
Why?
|
| K562 Cells | 1 | 2015 | 640 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2013 | 102 | 0.030 |
Why?
|
| Safety | 1 | 2017 | 1148 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 532 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 1446 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 148 | 0.030 |
Why?
|
| Hyperplasia | 2 | 1995 | 1155 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1986 | 2186 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4713 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1995 | 255 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20080 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 2 | 2007 | 900 | 0.030 |
Why?
|
| Software | 2 | 2018 | 4419 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 419 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 13502 | 0.030 |
Why?
|
| Gene Transfer Techniques | 3 | 2004 | 1204 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 724 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 1001 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 418 | 0.020 |
Why?
|
| Acute Disease | 4 | 2008 | 7269 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 3707 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 209 | 0.020 |
Why?
|
| Azepines | 1 | 2014 | 330 | 0.020 |
Why?
|
| Vincristine | 3 | 2002 | 1039 | 0.020 |
Why?
|
| S Phase | 2 | 2008 | 422 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 84 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 642 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 420 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 686 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 295 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2011 | 61 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2015 | 3539 | 0.020 |
Why?
|
| Skin | 3 | 2014 | 4466 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2015 | 951 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 798 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 116 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 545 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2003 | 4169 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2006 | 1433 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1693 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 1990 | 92 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2221 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 802 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 959 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2017 | 5649 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 581 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2011 | 169 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 900 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1088 | 0.020 |
Why?
|
| Rabbits | 2 | 2009 | 4773 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2011 | 118 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 165 | 0.020 |
Why?
|
| Genome | 2 | 2009 | 1739 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 778 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 251 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1994 | 967 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 530 | 0.020 |
Why?
|
| RNA, Neoplasm | 2 | 2008 | 749 | 0.020 |
Why?
|
| COS Cells | 2 | 2003 | 1129 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1060 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 503 | 0.020 |
Why?
|
| Recurrence | 3 | 2007 | 8482 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1994 | 720 | 0.020 |
Why?
|
| Cell Membrane Permeability | 2 | 2009 | 575 | 0.020 |
Why?
|
| Gene Expression | 4 | 2006 | 7588 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 605 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4035 | 0.020 |
Why?
|
| Cytogenetics | 1 | 2010 | 198 | 0.020 |
Why?
|
| Prednisone | 3 | 2002 | 1565 | 0.020 |
Why?
|
| Thrombopoiesis | 1 | 2011 | 164 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 2 | 2000 | 351 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1738 | 0.020 |
Why?
|
| Adenine | 1 | 2015 | 975 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2005 | 1900 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2009 | 2058 | 0.020 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2009 | 25 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1895 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2013 | 619 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 1485 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2015 | 1521 | 0.020 |
Why?
|
| Stem Cells | 3 | 2011 | 3523 | 0.020 |
Why?
|
| Dogs | 2 | 1984 | 3841 | 0.020 |
Why?
|
| Morphogenesis | 2 | 2004 | 740 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1972 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 414 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1999 | 3765 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2009 | 421 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 537 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2017 | 3486 | 0.020 |
Why?
|
| Insecticides | 1 | 2010 | 191 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 1411 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2009 | 1484 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 904 | 0.020 |
Why?
|
| Cyclophosphamide | 3 | 2002 | 2221 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2009 | 452 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 665 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 1993 | 1021 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2018 | 65017 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 2006 | 2698 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2003 | 829 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 482 | 0.020 |
Why?
|
| Trisomy | 1 | 1989 | 260 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2000 | 256 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14660 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 727 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2009 | 292 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 584 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 529 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2011 | 484 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 77 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2013 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1387 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2007 | 32 | 0.020 |
Why?
|
| Inflammation | 1 | 2007 | 10756 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 734 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2557 | 0.020 |
Why?
|
| Dopa Decarboxylase | 1 | 2006 | 14 | 0.020 |
Why?
|
| Syndrome | 3 | 2000 | 3280 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1672 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 616 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
| Capsid Proteins | 1 | 2010 | 467 | 0.020 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2006 | 37 | 0.020 |
Why?
|
| Erythrocytes | 3 | 1982 | 2415 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2001 | 649 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2003 | 1342 | 0.020 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 565 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6498 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3804 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1881 | 0.020 |
Why?
|
| Ploidies | 1 | 2007 | 275 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 311 | 0.020 |
Why?
|
| Piperidines | 1 | 2015 | 1650 | 0.020 |
Why?
|
| DNA Replication | 1 | 1993 | 1412 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2006 | 122 | 0.020 |
Why?
|
| Organ Specificity | 2 | 2004 | 1955 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1855 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 992 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 772 | 0.020 |
Why?
|
| RNA | 2 | 2006 | 2722 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 1827 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2448 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2007 | 317 | 0.020 |
Why?
|
| Integrases | 1 | 2008 | 516 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 877 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1792 | 0.020 |
Why?
|
| Calcitonin | 1 | 2006 | 330 | 0.020 |
Why?
|
| Adipocytes | 1 | 2012 | 1179 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1985 | 119 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2014 | 1089 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 401 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 176 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 670 | 0.020 |
Why?
|
| Reed-Sternberg Cells | 1 | 2005 | 72 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2004 | 3682 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2006 | 211 | 0.020 |
Why?
|
| Leukoplakia, Hairy | 1 | 2004 | 9 | 0.010 |
Why?
|
| DNA, Viral | 2 | 2004 | 2194 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6828 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3844 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 480 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 416 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 2007 | 311 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2932 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 476 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2007 | 554 | 0.010 |
Why?
|
| Autoradiography | 1 | 1985 | 730 | 0.010 |
Why?
|
| Contactins | 1 | 2003 | 21 | 0.010 |
Why?
|
| Immunocompetence | 1 | 2004 | 138 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2006 | 595 | 0.010 |
Why?
|
| Biotinylation | 1 | 2004 | 184 | 0.010 |
Why?
|
| Up-Regulation | 2 | 2003 | 4122 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 459 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3078 | 0.010 |
Why?
|
| Immune Sera | 1 | 1984 | 613 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 530 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2003 | 107 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2004 | 426 | 0.010 |
Why?
|
| Mosaicism | 1 | 2007 | 466 | 0.010 |
Why?
|
| Calorimetry | 1 | 2003 | 129 | 0.010 |
Why?
|
| Kinetics | 1 | 2011 | 6377 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3094 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2015 | 54303 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2008 | 820 | 0.010 |
Why?
|
| Leukemic Infiltration | 1 | 2003 | 47 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2006 | 541 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12960 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2008 | 1326 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1999 | 8056 | 0.010 |
Why?
|
| Static Electricity | 1 | 2003 | 261 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2008 | 1152 | 0.010 |
Why?
|
| DNA Damage | 1 | 2012 | 2442 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2004 | 495 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2006 | 814 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2006 | 591 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 899 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 513 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 1726 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1990 | 1373 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 458 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 333 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 929 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2006 | 4090 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1788 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 435 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 2003 | 198 | 0.010 |
Why?
|
| Biophysics | 1 | 2003 | 380 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2010 | 41335 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1982 | 197 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 824 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2558 | 0.010 |
Why?
|
| Melanocytes | 1 | 2005 | 512 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2003 | 371 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 635 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2672 | 0.010 |
Why?
|
| Viremia | 1 | 2004 | 707 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1984 | 708 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 898 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1985 | 1456 | 0.010 |
Why?
|
| Oncostatin M | 1 | 2000 | 42 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2000 | 95 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2016 | 4642 | 0.010 |
Why?
|
| Women's Health | 1 | 2010 | 2056 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 358 | 0.010 |
Why?
|
| Risk Factors | 4 | 2010 | 74359 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2012 | 3301 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1989 | 1439 | 0.010 |
Why?
|
| Electroporation | 1 | 2001 | 255 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2000 | 111 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 1084 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3047 | 0.010 |
Why?
|
| Epithelium | 1 | 1984 | 1605 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2000 | 130 | 0.010 |
Why?
|
| Heterozygote | 1 | 2007 | 2798 | 0.010 |
Why?
|
| Leukopoiesis | 1 | 1999 | 55 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 562 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3380 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 456 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2000 | 287 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1006 | 0.010 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1999 | 23 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2000 | 128 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 867 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 687 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2879 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.010 |
Why?
|
| Genes, abl | 1 | 1998 | 69 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11152 | 0.010 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1998 | 53 | 0.010 |
Why?
|
| Genetic Markers | 2 | 1996 | 2608 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1982 | 633 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 1999 | 138 | 0.010 |
Why?
|
| Infant | 3 | 2006 | 36060 | 0.010 |
Why?
|
| Blast Crisis | 1 | 1998 | 101 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3442 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3959 | 0.010 |
Why?
|
| Zinc | 2 | 1981 | 689 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1998 | 455 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 1077 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 2432 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1998 | 189 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 2569 | 0.010 |
Why?
|
| Genes | 1 | 2001 | 1845 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 2002 | 506 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9716 | 0.010 |
Why?
|
| Granulocytes | 1 | 1999 | 551 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 23711 | 0.010 |
Why?
|
| Liver | 2 | 2004 | 7509 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 425 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6465 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1753 | 0.010 |
Why?
|
| Virus Latency | 1 | 2000 | 362 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1697 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2298 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 1234 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1996 | 109 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1996 | 248 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1996 | 364 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2004 | 2838 | 0.010 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2007 | 1724 | 0.010 |
Why?
|
| Kidney | 2 | 2003 | 7064 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6238 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2000 | 1690 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 4357 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13314 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1995 | 156 | 0.010 |
Why?
|
| Mitoxantrone | 1 | 1995 | 149 | 0.010 |
Why?
|
| Viral Load | 1 | 2004 | 3322 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1292 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 7343 | 0.010 |
Why?
|
| Ifosfamide | 1 | 1995 | 232 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 783 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1994 | 433 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 1710 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1995 | 282 | 0.010 |
Why?
|
| Replication Protein A | 1 | 1993 | 52 | 0.010 |
Why?
|
| Etoposide | 1 | 1995 | 630 | 0.010 |
Why?
|
| Fibrosis | 1 | 2000 | 2042 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18416 | 0.010 |
Why?
|
| Cytarabine | 1 | 1995 | 696 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1993 | 257 | 0.010 |
Why?
|
| Muscles | 1 | 1997 | 1581 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 1997 | 1007 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 1981 | 1056 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1999 | 1343 | 0.010 |
Why?
|
| Carboplatin | 1 | 1995 | 788 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4433 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1989 | 6315 | 0.010 |
Why?
|
| Glutathione | 1 | 1993 | 582 | 0.010 |
Why?
|
| Microspheres | 1 | 1993 | 787 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1995 | 1832 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2002 | 2003 | 0.010 |
Why?
|
| Haplotypes | 1 | 1996 | 2764 | 0.010 |
Why?
|
| Brain | 1 | 2016 | 26951 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1997 | 4810 | 0.010 |
Why?
|
| Pedigree | 1 | 1996 | 4578 | 0.000 |
Why?
|
| Pregnancy | 2 | 2004 | 29749 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15789 | 0.000 |
Why?
|
| Gestational Age | 1 | 1996 | 3565 | 0.000 |
Why?
|
| Karyotyping | 1 | 1989 | 1171 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4925 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 26181 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1993 | 2698 | 0.000 |
Why?
|
| Calcimycin | 1 | 1982 | 213 | 0.000 |
Why?
|
| United States | 1 | 2010 | 72461 | 0.000 |
Why?
|
| Cell Aggregation | 1 | 1982 | 239 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1993 | 4219 | 0.000 |
Why?
|
| Connexins | 1 | 1982 | 351 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 3826 | 0.000 |
Why?
|
| Chickens | 1 | 1982 | 860 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1979 | 282 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8547 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1998 | 80372 | 0.000 |
Why?
|
| Hemolysis | 1 | 1979 | 423 | 0.000 |
Why?
|
| Incidence | 1 | 1994 | 21392 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 21025 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1979 | 832 | 0.000 |
Why?
|
| Anesthetics, Local | 1 | 1981 | 1001 | 0.000 |
Why?
|
| Antipsychotic Agents | 1 | 1981 | 3061 | 0.000 |
Why?
|